OSTN (81-102) [6050]



OSTN (81-102)


SMILES CC(C)C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C
InChIKey KWLGDIDCTYJFLH-URZJMNTHSA-N
Sequence KRSFSGFGSPLDRLSAGSVDHK
HELM PEPTIDE1{K.R.S.F.S.G.F.G.S.P.L.D.R.L.S.A.G.S.V.D.H.K.[am]}$$$$

Chemical Properties

Hydrogen bond acceptors 35
Hydrogen bond donors 36
Rotatable bonds 78
Log P -15.124
Molecular weight (Da) 2346.2
Stereochemistry info unspecified

Database connections



No bioactivity data available.

OSTN (81-102)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.